Table 1 Do you see patients with the following problems following treatment for DTC?
From: Treatment related morbidity in differentiated thyroid cancer–a survey of clinicians
Complication (number of responders) | Never/NA | Rarely (≤1/year) | Occasionally (≤1/month) | Commonly (≤6/month) | Frequently (>6/month) |
|---|---|---|---|---|---|
Temporary hypocalcaemia (118) | 9 (7.6%) | 18 (15.3%) | 63 (53.4%) | 28 (23.7%) | 0 (0.0%) |
Long term hypocalcaemia (118) | 10 (8.5%) | 51 (43.2%) | 43 (36.4%) | 14 (11.9%) | 0 (0.0%) |
Significant voice change (117) | 6 (5.1%) | 70 (59.8%) | 36 (30.8%) | 5 (4.3%) | 0 (0.0%) |
Symptoms/poor quality of life from TSH suppression (118) | 19 (16.1%) | 57 (48.3%) | 30 (25.4%) | 12 (10.2%) | 0 (0.0%) |
Bone/CVS complications from TSH suppression (118) | 41 (34.7%) | 58 (49.2%) | 19 (16.1%) | 0 (0.0%) | 0 (0.0%) |